news aktuell GmbHnews aktuell GmbH

DAS Environmental Experts - German Green Technology from DAS Environmental Experts for Swiss DSM Nutritional Products AG

Del
Moving Bed Biofilm Reactor for sustainable wastewater treatment for the food industry

Dresden/Germany, 29 March 2021. Increasing production capacities have stretched the existing wastewater treatment plant at the chemical company DSM Nutritional Products in Switzerland to its limits. Wastewater characteristics of the chemical industry with strict regulations of the beverage and food industry - the experts of German green technology experts of DAS Environmental Expert GmbH (DAS EE) mastered the challenge and installed a two-stage MBBR plant.

At the site DSM operates the world's largest production facility for vitamin E. The plant also produces pharmaceuticals, substances for the cosmetics industry, dietary supplements and additives such as vitamins, carotenoids and folic acid. The expertise of the Dresden-based environmental technologists was required to handle not only the increased volume, but also the purification of the wastewater. “The wastewater characteristics correspond to those of the chemical industry - but the regulations to be met are similar to those for the beverage and food industries. These strict limits must be reliably met even after the production expansion”, reports Karl Ruediger, project manager at DAS EE.

Initially, a temporary addition to the existing wastewater treatment plant was planned, because the production expansion at the site was accompanied by an increase of the hydraulic load. DAS EE opted for a two-stage MBBR plant (Moving Bed Biofilm Reactor) in order to quickly adapt the wastewater treatment to the planned increase in production.Today, the plant is used under production conditions in the food industry. DAS EE supports DSM with supervision. Online remote maintenance ensures a continuous cost-saving service.

www.das-ee.com

Full report and visuals: http://bit.ly/DAS_EE_DSM

Contact: WeichertMehner (Press), Robert Weichert,
+49351 50140202,
robert.weichert@weichertmehner.com

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release

Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye